Epizyme, Inc. (EPZM) Social Stream
Featured Post From StockTwits About EPZM
$EPZM Look at the pieces of this puzzle:melanieporter, published July 2, 2020
This stock drastically underperformed during its FDA approval. In fact, the major shareholders and the CEO sold A LOT of shares right after the approval (???) Even after that, Morgan Stanley maintains their $31 PT. Plus, EPZM Relative Strength Rating just increased as well.
Hmmm, to me, it seems like there is something going on behind the scenes, wouldn't you agree?